health
commiss
play
vital
role
regul
diagnos
treatment
across
countri
littl
month
six
edit
guidelin
publish
incorpor
latest
clinic
feedback
research
progress
recent
edit
compar
edit
edit
make
chang
basic
concept
mainli
focus
variou
revis
updat
regard
transmiss
rout
clinic
manifest
children
etiolog
diagnosi
diagnost
criteria
exclus
criteria
suspect
case
importantli
clinic
warn
sign
treatment
sever
critic
ill
patient
well
refin
followup
observ
furthermor
addit
success
public
sever
diagnosi
treatment
guidelin
sever
critic
case
militari
local
unit
also
issu
instruct
articl
review
address
hotspot
key
issu
pertain
first
time
basi
latest
research
develop
edit
guidelin
ad
descript
patholog
chang
occur
organ
patient
particular
focu
pulmonari
lesion
guidelin
state
lung
patient
exhibit
pulmonari
consolid
differ
degre
well
presenc
intraalveolar
serou
fluid
fibromyxoid
exud
hyalinemembran
format
exud
consist
mainli
mononuclear
macrophag
although
multinucl
giant
cell
also
common
addit
signific
hyperplasia
type
ii
pneumocyt
well
desquam
observ
wherea
inclus
bodi
evid
insid
type
ii
pneumocyt
macrophag
find
confirm
critic
ill
patient
treatment
outcom
convent
respiratori
support
poor
primarili
due
signific
deterior
pulmonari
gasexchang
capac
result
diffus
alveolar
damag
lung
parenchyma
furthermor
edit
guidelin
emphas
affect
multipl
organ
specif
diseas
lead
significantli
reduc
lymphocyt
count
spleen
lymph
node
well
consider
reduct
trilineag
hematopoiesi
bone
marrow
result
suggest
attack
wide
rang
organ
spread
extens
worldwid
particular
effect
immun
system
import
risk
factor
poor
patient
prognosi
presenc
larg
number
macrophag
variou
organsespeci
lung
spleenind
research
investig
macrophagemedi
inflamm
priorit
note
find
preval
obtain
sever
case
basi
latest
research
develop
edit
guidelin
includ
two
addit
section
laboratori
investig
latest
research
develop
regard
etiolog
examin
includ
recent
publish
articl
unit
state
emerg
infecti
diseas
report
asymptomat
patient
confirm
posit
basi
viral
nucleic
acid
detect
stool
specimen
guangzhou
research
institut
respiratori
diseas
announc
success
isol
stool
sampl
infect
patient
therefor
edit
guidelin
recommend
adopt
revers
transcriptasepolymeras
chain
reaction
andor
nextgener
sequenc
technolog
detect
presenc
nasopharyng
swab
sputum
lower
respiratori
tract
secret
well
blood
stool
sampl
guidelin
also
suggest
test
perform
use
sampl
lower
respiratori
tract
ie
sputum
airway
suction
accur
find
indic
transmit
respiratori
secret
also
fece
even
blood
make
potenti
sourc
infect
suscept
individu
addit
emphasi
use
lower
respiratori
tract
sampl
rather
nasopharyng
swab
support
limit
sensit
latter
given
full
consider
clinic
practic
immunoglobulin
ig
antibodi
appear
test
posit
day
onset
symptom
wherea
titer
igg
antibodi
shown
elev
recoveri
phase
compar
acut
phase
regard
detect
bloodspecif
igm
igg
antibodi
set
examin
test
peripher
blood
level
igm
igg
patient
newli
diagnos
reveal
posit
rate
respect
addit
examin
reveal
posit
rate
remain
within
first
day
onset
symptom
howev
day
posit
rate
increas
substanti
reach
igm
igg
indic
extrem
high
clinic
complianc
rate
current
multipl
manufactur
produc
clinic
detect
kit
base
variou
method
includ
colloid
gold
chemiluminesc
enzymelink
immunosorb
assay
nevertheless
data
regard
efficaci
method
detect
earli
infect
scarc
therefor
still
sever
unansw
question
regard
use
method
base
detect
peripher
blood
igm
igg
level
earli
screen
diagnost
approach
identifi
optim
window
sampl
detect
high
posit
rate
reliabl
method
thu
method
still
requir
clinic
verif
addit
take
time
gener
antibodi
infect
length
window
antibodi
detect
also
need
clarif
nevertheless
author
believ
supplement
nucleic
acid
detect
peripher
blood
igm
igg
test
highli
use
diagnosi
especi
evalu
therapeut
effect
plasma
therapi
statu
patient
autoimmun
function
earli
predict
evalu
diseas
sever
extrem
import
patient
prognosi
howev
novel
diseas
clinic
experi
summari
creat
instep
treatment
process
clinic
predict
marker
use
guid
treatment
promptli
establish
review
success
treatment
outcom
data
accumul
past
experi
compar
previou
version
edit
guidelin
inform
regard
clinic
warn
sign
sever
critic
case
adult
includ
follow
progress
reduct
peripher
blood
lymphocyt
level
progress
increas
peripher
inflammatori
cytokin
level
interleukin
il
creactiv
protein
crp
progress
increas
lactat
level
rapid
progress
lung
lesion
short
term
previou
studi
report
patient
diagnos
experi
mildtomoder
symptom
howev
patient
suddenli
deterior
rapidli
progress
sever
critic
statu
consequ
increas
mortal
rate
contrast
establish
clinic
warn
sign
enabl
prompt
identif
patient
treatment
care
priorit
deliv
time
manner
reduc
mortal
howev
whether
implement
indic
play
role
earli
indic
diseas
sever
requir
clinic
verif
role
corticosteroid
treatment
remain
controversi
although
chang
associ
topic
made
edit
guidelin
diagnosi
treatment
guidelin
sever
critic
case
trial
edit
recommend
regard
glucocorticoid
therapi
includ
current
clinic
evid
glucocorticoid
therapi
improv
prognosi
patient
recommend
routin
use
patient
exhibit
progress
deterior
oxygen
rapid
radiolog
progress
high
level
cytokin
storm
shortterm
administr
methylprednisolon
dose
mg
everi
h
total
day
consid
administr
contraind
glucocorticoid
therapi
confirm
addit
chines
militari
local
govern
unit
publish
consensu
statement
instruct
cautious
recommend
shortterm
administr
certain
dose
glucocorticoid
patient
earlystag
whose
condit
rapidli
deterior
support
data
patient
beij
china
receiv
glucocorticoid
found
glucocorticoid
administr
independ
risk
factor
associ
develop
acidbas
disord
author
believ
despit
immunosuppress
effect
glucocorticoid
inhibit
cytokin
storm
also
induc
problem
suscept
secondari
infect
disturb
homeostasi
prolong
viru
shed
therefor
essenti
individu
administr
glucocorticoid
base
data
recommend
glucocorticoid
therapi
implement
diseas
earli
stage
within
day
onset
progress
rapidli
rapid
diseas
deterior
within
h
well
substanti
increas
exud
pulmonari
lesion
accompani
sever
cytokin
storm
valu
time
normal
valu
patient
exhibit
obviou
cellular
immunosuppress
absolut
lymphocyt
count
l
drug
administ
appropri
dosag
medium
dose
mgday
shortterm
cours
usual
day
day
due
accumul
clinic
experi
treatment
recommend
sever
critic
ill
patient
significantli
improv
refin
edit
guidelin
provid
supplementari
inform
treatment
section
includ
emphas
import
lungprotect
ventil
defin
indic
extracorpor
membran
oxygen
continu
renal
replac
therapi
detail
well
close
monitor
hemodynam
data
term
new
treatment
method
addit
provis
refin
specif
indic
plasma
therapi
tocilizumab
ig
edit
guidelin
also
includ
relev
recommend
suggest
regard
treatment
pregnant
women
exist
clinic
studi
indic
mortal
risk
elderli
patient
significantli
higher
age
group
hypertens
diabet
may
independ
risk
factor
poor
prognosi
patient
popul
therefor
necessari
devot
special
attent
elderli
patient
especi
chronic
underli
diseas
whose
treatment
cours
consid
primari
infect
altern
rehabilit
patient
includ
physiolog
psycholog
compon
extrem
import
treatment
cours
respiratori
rehabilit
guidelin
edit
issu
respiratori
rehabilit
committe
chines
associ
rehabilit
medicin
instruct
help
guid
rehabilit
patient
conclus
highli
infecti
diseas
becom
global
threat
public
health
therefor
essenti
studi
viru
promptli
learn
clinic
experi
establish
global
collabor
fight
diseas
togeth
order
achiev
victori
studi
support
grant
nation
natur
scienc
foundat
china
none
